400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2024-04-25
综合护理平台开发商
健康管理
心理咨询
Quiet Capital;
Quiet Capital;
8VC;
8VC;
Bling Capital;
Virtue Ventures;
Able Partners;
Healthier Capital
2024-04-24
女性中年健康虚拟护理平台运营商
医疗服务
远程医疗
Emerson Collective;
Emerson Collective;
SemperVirens VC;
SemperVirens VC;
Felicis Ventures;
GingerBread Capital;
SteelSky Ventures;
Black Angel Group;
Memorial Hermann;
K50 Ventures;
Operator Collective;
1843 Capital;
G9 Ventures;
Muse Capital;
Able Partners;
f7 Ventures;
Avestria Ventures;
Icon Ventures
2023-09-26
远程医疗服务提供商
学术研究
综合服务
2023-07-12
健康管理应用程序开发商
健康管理
健康咨询
Bling Capital;
Bling Capital;
Able Partners;
Able Partners;
Bow Capital;
SciFi VC;
South Park Commons;
Khosla Ventures
2023-01-25
心理治疗实践服务提供商
健康管理
心理咨询
Gaingels;
Gaingels;
PsyMed Ventures;
PsyMed Ventures;
Satori Capital;
Palo Santo Venture Fund;
AlleyCorp;
Fifty Years;
Able Partners;
Coalition Operators;
Union Square Ventures
2022-09-19
医疗保健服务提供商
医疗服务
治疗服务
Necessary Ventures;
Necessary Ventures;
Vamos Ventures;
Vamos Ventures;
Able Partners;
ANIMO Ventures
2022-02-16
儿童保育和早期教育平台提供商
康复与护理服务
医疗服务
CityRock Venture;
CityRock Venture;
Tribeca Venture Partners;
Tribeca Venture Partners;
Hither Creek Ventures;
Able Partners;
Conversion Ventures;
Rethink Education
2022-01-04
医疗保健服务商
综合服务
社群服务
American Association of Retired Persons;
American Association of Retired Persons;
Entrée Capital;
Entrée Capital;
Indicator Ventures;
Service Provider Capital;
8VC;
Able Partners;
Slow Ventures;
SemperVirens VC;
Greycroft;
Cue Ball;
Founder Collective
2021-11-04
皮肤应用电子传感器研发商
医疗器械
诊断/监护器械
RiverVest;
RiverVest;
JDRF T1D Fund;
JDRF T1D Fund;
Able Partners;
EOFlow;
Cirrus Logic;
大正制药;
The Broe Group;
Senvest Capital;
Hikma Ventures;
M Ventures;
Aphelion Capital;
Falcon Edge Capital;
Longevity Vision Fund;
Ascensia Diabetes Care;
The Global Health Investment Fund;
AXA IM Alts
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10